Enterprise Value to EBITDA Multiple ratio Analysis of Novo Nordisk A/S - Deep Dive
WARN : Please note that some of the values may not be in base currency

Latest FY EV to EBITDA
Period Ending - Dec-23

5.46


Very Good EV to EBITDA
Period Ending - Dec-22
8.13

Good EV to EBITDA
Growth
-32.90 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23

4.95


Excellent EV to EBITDA
EV to EBITDA Analysis of Novo Nordisk A/S
EV to EBITDA Ratio of NVO drastically fell by -32.90 % this year.
EV to EBITDA Ratio with value of 10.89 was highest in Year Dec-19 in last Five Years.
EV to EBITDA Ratio of NVO trending down for at least three Years.
Latest EV to EBITDA Ratio with value of 5.46 is lower than Average EV to EBITDA of 8.95 in last five years.
Other EV to EBITDA Related Info of NVO that may interest you.
Novo Nordisk A/S Overview
CodePricePrevious PricePrice ChangeSector
NVO135.28132.8 1.87 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued.    more ..
Enterprise Value to EBITDA Multiple  Formula

EV to EBITDA Related Ratios
EBITDAMarginEVToRevenuePriceToEarningRatio

Tsr Value Index
Good Value
FY - Historical Enterprise Value to EBITDA Multiple of Novo Nordisk A/S
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
EV to EBITDA5.468.139.8510.4310.8912.4112.58
Change-32.90 %-17.46 %-5.53 %-4.29 %-12.24 %-1.29 %-3.79 %
You are view first 7 Records. Log in to view all 39 in Premium view
FY Chart of Enterprise Value to EBITDA Multiple of Novo Nordisk A/S


Note : All Data Generated at the End of Trading Hours (EOD Data)